Jupiter Financial Statements From 2010 to 2025

JUNS Stock  USD 1.07  0.03  2.73%   
Jupiter Neurosciences,'s financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Jupiter Neurosciences,'s valuation are provided below:
Gross Profit
-2.2 M
Market Capitalization
37.9 M
Earnings Share
(0.23)
There are over one hundred nineteen available fundamental trends for Jupiter Neurosciences,, which can be analyzed over time and compared to other ratios. All traders should confirm Jupiter Neurosciences,'s regular fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction. Market Cap is likely to gain to about 323.4 M in 2025. Enterprise Value is likely to gain to about 319.6 M in 2025

Jupiter Neurosciences, Total Revenue

0.0

Check Jupiter Neurosciences, financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Jupiter Neurosciences,'s main balance sheet or income statement drivers, such as Interest Expense of 303 K, Selling General Administrative of 2.6 M or Other Operating Expenses of 3.7 M, as well as many indicators such as Price To Sales Ratio of 731, Dividend Yield of 0.0 or PTB Ratio of 77.51. Jupiter financial statements analysis is a perfect complement when working with Jupiter Neurosciences, Valuation or Volatility modules.
  
Build AI portfolio with Jupiter Stock
Check out the analysis of Jupiter Neurosciences, Correlation against competitors.

Jupiter Neurosciences, Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets6.5 M6.2 M898.7 K
Slightly volatile
Short and Long Term Debt Total206.9 K217.8 K1.1 M
Pretty Stable
Other Current LiabilitiesM1.5 M3.7 M
Pretty Stable
Total Current LiabilitiesMMM
Pretty Stable
Accounts Payable237.5 K278.7 K169.5 K
Slightly volatile
CashM3.8 M523.2 K
Slightly volatile
Cash And Short Term InvestmentsM3.8 M523.2 K
Slightly volatile
Common Stock Shares Outstanding22.3 M28.8 M13.9 M
Slightly volatile
Liabilities And Stockholders Equity6.5 M6.2 M898.7 K
Slightly volatile
Other Current Assets924.8 K880.8 K136.7 K
Slightly volatile
Other Stockholder Equity31.7 M30.2 M8.5 M
Slightly volatile
Total Liabilities1.9 MM4.9 M
Slightly volatile
Total Current Assets4.9 M4.7 M667.9 K
Slightly volatile
Short Term Debt186.7 K196.5 K1.1 M
Slightly volatile
Common Stock1.9 K3.3 K1.1 K
Slightly volatile
Net Receivables101 K113.6 K123.9 K
Slightly volatile
Short and Long Term Debt139.1 K146.4 K354.6 K
Slightly volatile
Capital Stock2.2 K3.3 K1.1 K
Slightly volatile
Long Term Debt85.4 K96 K104.7 K
Slightly volatile

Jupiter Neurosciences, Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Expense303 K248.4 K300.6 K
Very volatile
Selling General Administrative2.6 M2.6 M1.9 M
Slightly volatile
Other Operating Expenses3.7 M3.1 M2.7 M
Slightly volatile
Research Development822 K492.7 K822.4 K
Slightly volatile
Total Operating Expenses3.7 M3.1 M2.7 M
Slightly volatile
Interest Income5.8 K5.6 K815
Slightly volatile
Gross Profit199.5 K210 K868.9 K
Slightly volatile
Income Tax Expense143.3 K161.3 K175.8 K
Slightly volatile

Jupiter Neurosciences, Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Stock Based Compensation1.2 M1.8 MM
Slightly volatile
Begin Period Cash Flow27.1 K28.5 K64 K
Slightly volatile
Other Cashflows From Financing Activities11.9 M11.4 M2.8 M
Slightly volatile
Total Cash From Financing ActivitiesM7.7 M1.3 M
Slightly volatile
End Period Cash FlowM3.8 M523.2 K
Slightly volatile
Change To Inventory36 K40.5 K44.1 K
Slightly volatile
Depreciation34.6 K39 K42.5 K
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio731696220
Slightly volatile
Days Sales Outstanding32.7336.8240.1438
Slightly volatile
Average Payables174.5 K234.1 K198.8 K
Slightly volatile
Stock Based Compensation To Revenue1.623.151.2076
Slightly volatile
EV To Sales739703222
Slightly volatile
Sales General And Administrative To Revenue11.0310.513.9246
Slightly volatile
Research And Ddevelopement To Revenue2.073.642.0058
Slightly volatile
Capex To Revenue0.00.00.0
Slightly volatile
Cash Per Share0.140.1310.0209
Slightly volatile
Income Quality1.681.60310.292
Slightly volatile
Current Ratio2.432.31450.3111
Slightly volatile
Receivables Turnover7.148.038.7548
Slightly volatile
Average Receivables50.5 K56.8 K61.9 K
Slightly volatile
Revenue Per Share0.00780.00820.0947
Slightly volatile
Interest Debt Per Share0.01540.01620.1267
Slightly volatile
Debt To Assets0.03340.0351124
Slightly volatile
Operating Cycle32.7336.8240.1438
Slightly volatile
Ebt Per Ebit1.250.78921.2928
Slightly volatile
Quick Ratio2.432.31450.3111
Slightly volatile
Net Income Per E B T0.830.941.0229
Slightly volatile
Cash Ratio1.971.87620.2481
Slightly volatile
Cash Conversion Cycle32.7336.8240.1438
Slightly volatile
Days Of Sales Outstanding32.7336.8240.1438
Slightly volatile
Fixed Asset Turnover2.461.652.7267
Slightly volatile
Debt Ratio0.03340.0351124
Slightly volatile
Price Sales Ratio731696220
Slightly volatile
Asset Turnover1.461.141.7537
Slightly volatile

Jupiter Neurosciences, Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap323.4 M308 M98.3 M
Slightly volatile
Enterprise Value319.6 M304.4 M98.8 M
Slightly volatile

Jupiter Fundamental Market Drivers

Forward Price Earnings18.3486
Cash And Short Term Investments3.8 M

About Jupiter Neurosciences, Financial Statements

Jupiter Neurosciences, shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Jupiter Neurosciences, investors may analyze each financial statement separately, they are all interrelated. The changes in Jupiter Neurosciences,'s assets and liabilities, for example, are also reflected in the revenues and expenses on on Jupiter Neurosciences,'s income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Stock Based Compensation To Revenue 3.15  1.62 
Sales General And Administrative To Revenue 10.51  11.03 
Research And Ddevelopement To Revenue 3.64  2.07 
Revenue Per Share 0.01  0.01 
Ebit Per Revenue(16.92)(16.07)

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Jupiter Stock Analysis

When running Jupiter Neurosciences,'s price analysis, check to measure Jupiter Neurosciences,'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jupiter Neurosciences, is operating at the current time. Most of Jupiter Neurosciences,'s value examination focuses on studying past and present price action to predict the probability of Jupiter Neurosciences,'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jupiter Neurosciences,'s price. Additionally, you may evaluate how the addition of Jupiter Neurosciences, to your portfolios can decrease your overall portfolio volatility.